Silvia De Santis1,2, Matteo Bastiani2, Henk Jansma2, Amgad Droby3, Pierre Kolber3, Eberhard Pracht4, Tony Stoecker4, Frauke Zipp3, and Alard Roebroeck2
1Cardiff University, CUBRIC, Cardiff, United Kingdom, 2Dept. of Cognitive Neuroscience, Faculty of Psychology & Neuroscience, Maastricht University, Maastricht, Netherlands, 3Department of Neurology and Neuromaging Center, University Medical Center of the Johannes Gutenberg University, Mainz, Germany, 4German Center for Neurodegenerative diseases, Bonn, Germany
Synopsis
Aim of this work was
to test the ability of conventional (i.e., DTI) and advanced (i.e., CHARMED,
stretched exponential) diffusion methods to differentiate between Multiple
Sclerosis lesions, normal appearing white matter and healthy controls, at both
3T and 7T. Advanced dMRI at 7T gives the best discriminating power between MS
lesions and healthy tissue across WM; DTI is appropriate in areas of low fiber
dispersion like the corpus callosum.PURPOSE
Multiple sclerosis
(MS) is an immune-mediated process in which an abnormal response of the immune
system is directed against myelin, causing focal demyelination and axonal loss
to variable extent. Diffusion tensor imaging (DTI)[1] detects microstructural
white matter (WM) damage in MS[2]. Differences in fractional anisotropy (FA), mean
diffusivity (MD), axial (L1) and radial diffusivity (RD) between patients and
healthy controls (HC) can be observed at the focal lesion site as well as in
the normal appearing WM (NAWM). Although DTI is extremely sensitive to changes
in microstructure, it has limited pathologic specificity[3]. More advanced
diffusion techniques can better inform about the pathophysiologic processes
taking place in MS [4,5]. Here, we apply for the first time two multi-shell
diffusion MRI approaches: the composite hindered and restricted model of
diffusion (CHARMED)[6] and the stretched exponential model (SEM)[7]. CHARMED
provides maps of the restricted water fraction (FR), a proxy for the axonal
density, while SEM generates maps of the heterogeneity index (MA), sensitive to
different diffusivity domains inside the voxel. Our aim was to assess the
ability of these methods to differentiate between MS lesions, NAWM and HC as
compared to the natural variability found in control tissue.
METHODS
7 MS patients and 5 age/gender-matched HC underwent a
comprehensive MRI protocol at 3T/7T, comprising: an MPRAGE(3T), multi-shell
diffusion with b=700/2000s/mm2 and 27/45 gradient orientations at 1.5mm
isotropic resolution (3T/7T), two double inversion recovery (DIR) acquisitions[8]
targeted to retain grey or WM signal respectively (3T/7T) and a high resolution
MP2RAGE(7T). Diffusion data were pre-processed using FSL-EDDY [9] and analysed
in native space using conventional DTI[10] (using only b=700s/mm2), using CHARMED[2]
and using SEM[3], to extract maps of FA,MD,L1,RD,FR,MA. All the maps were
linearly registered to the high resolution anatomical. For each subject, the
anatomical map was then nonlinearly warped to the FSL template using ANTs[11]
and the obtained transformation was applied to all diffusion maps. MS lesions
were manually segmented using the DIR maps(Fig.a); the lesion masks were then nonlinearly
warped to the template. The tracts affected by
the MS lesion were identified by using WM labels in standard space [12]. Then, for each subject and for each
lesion whose volume occupied more than 5% of the ROI, mean and standard
deviation(SD) of diffusion indices were calculated in the intersection between
the lesion area and the ROI, in the contralateral ROI (when present and not
affected by lesions) and in the same ROI across the healthy population, for a
total of 13 lesions monitored(Fig.b). For each index, the % change between HC
and lesion and between HC and contralateral NAWM (when present) was calculated
and normalized to the SD of the parameter in the HC. Then, the changes were averaged
casting the lesions in two groups: those outside the corpus callosum (CC), for
which also the difference between HC and NAWM was calculated, and those
affecting the CC. The differential performance between 3T and 7T was also
evaluated in terms of differences between values in the lesions and in the healthy
corresponding ROI.
RESULTS AND DISCUSSION
For lesions affecting WM areas outside
the CC(Fig.c), FR and MA are the most sensitive indices at 3T, while FR is the
most sensitive index at 7T, when comparing the lesion site with healthy tissue.
Conversely, in the CC(Fig.d), which is characterized by a highly coherent fiber
organization, DTI indices (FA) have the best performance in detecting
differences between HC and lesion, closely followed by FR. This can be explained by the fact that in
tissue characterized by coherent fiber organization, the tensor model is
appropriate to describe the diffusion dynamics, while in areas of complex fiber
architecture, more advanced models are required[13]. FR shows consistent
discriminating performance across both cases. All indices show that NAWM has an
intermediate behavior between focal lesion and HC. FR has best performance at
3T in discriminating between healthy and NAWM, while MD has the best
performance at 7T(Fig.c). Interestingly, the performance of all indices is 1-3
times better at 7T than at 3T, except for MA (little or no impact of field
strength)(Fig.e).
CONCLUSIONS
At 7T, CHARMED-FR gives the
best discriminability between MS lesions and HC across the WM. In areas of low
fiber dispersion such as the CC, DTI-FA&L1 were found to discriminate well
the diffusion dynamics of the tissue, but showed less lesion discrimination
outside the CC. We therefore conclude that CHARMED (more than DTI) at 7T (more
than at 3T) can improve detection of MS lesions. Further statistical
quantification over a larger number of lesion sites can serve to validate these
findings.
Acknowledgements
No acknowledgement found.References
[1] Basser et al. J Magn Reson B 103 :247 (1994) [2] Werring et al Neurology 52:8 (1999)
[3] Wheeler-Kingshott and Cercignani MRM 61:1255
(2009) [4] Bester et al. Multiple Sclerosis
21:935 (2015) [5] Grussu et al
NeuroImage 111:590 (2015) [6] Assaf and Basser MRM
52:965 (2004) [7] Hall
and Barrick, MRM 59:447 (2008) [8] Pracht et al ISMRM 2014 [9] Jenkinson et al NeuroImage 62:782 (2012) [10] Leemans A et al. Proc. ISMRM (2009) [11] Avants et al. Insight J (2009) [12] Mori et al. NI 40:570
(2008) [13] De Santis et al NeuroImage
89:35 (2014)